Ultralife Corporation (ULBI) — Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023; filed March 21, 2024. Although the request references 2023 Q4, this is an annual filing. The filing provides some fourth-quarter information but does not present a complete standalone quarterly results summary in the supplied text. Dollar amounts below are in thousands, except per-share data.
Business context
Ultralife designs and manufactures batteries, charging systems, communications equipment and related engineered systems for government, defense and commercial customers. It reports Battery & Energy Products and Communications Systems segments.
Key financial metrics
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $158,644 | $131,840 |
| Gross profit / gross margin | $39,200 / 24.7% | $29,400 / 22.3% |
| Operating income | $9,475 | $129 |
| Net income (loss) attributable to Ultralife | $7,197 | $(119) |
| Diluted EPS | $0.44 | $(0.01) |
| Adjusted EBITDA (non-GAAP) | $15,703 | $6,575 |
| Cash provided by (used in) operating activities | $1,929 | $(1,263) |
| Capital expenditures | $2,552 | $1,679 |
| Cash, including restricted cash | $10,278 | $5,713 |
| Working capital / current ratio | $66,473 / 3.8 | $50,075 / 2.7 |
| Term loan and revolver principal outstanding at year-end | $6,167 and $19,580 | Not clearly stated as comparable principal balances in the filing text |
Year-end total debt principal was $25,747, including $2,000 of term-loan principal due in 2024. The revolving facility matures May 30, 2025; borrowings carry variable interest rates. The company reported compliance with its debt covenants. Cash flow from operations was positive, but working-capital growth absorbed $11,041, including higher receivables and inventory.
Material changes versus FY2022
- Revenue rose 20.3%. Battery & Energy Products revenue increased 8.3% to $129,953; Communications Systems revenue increased 142.2% to $28,691, largely from fulfillment of sizable defense-program orders.
- Commercial medical-device sales rose 35.2% to $36,945, helped by demand from a large medical-device OEM and the X-5 medical cart battery launch. Oil and gas sales increased 5.8% to $40,562.
- Government and defense revenue increased to $57,802, or 36% of total revenue, from $38,795, or 29%. U.S. government sales were approximately $43,476, or 27% of revenue.
- Gross margin improved 240 basis points. Management cited better timing of customer price increases, improved production planning and labor utilization, and more efficient new-product transitions.
- Operating expenses increased 1.6% to $29,725, but declined to 18.7% of revenue from 22.2%, reflecting operating leverage.
- Interest and financing expense increased to $2,016 from $951, primarily due to acquisition-related debt, working-capital funding and higher interest rates. Year-end backlog fell 6.7% to $103,535: Battery & Energy Products backlog rose 3.8% to $91,997, while Communications Systems backlog declined 48.4% to $11,538 after large orders were fulfilled.
Outlook, risks and unusual items
- Management cited backlog, customer relationships, diversified end markets, new products and margin-improvement actions as supporting sustainable profitable growth. It expects positive operating cash flow and believes cash and credit availability will meet financing and investment needs. No specific revenue or earnings guidance is provided.
- Research and development spending was $8,587 in 2023. Management said spending could increase by 10% or more in 2024 based on current initiatives.
- Conformal Wearable Battery development passed UN/DOT shipment testing in 2023; validation work was ongoing, with U.S. Government First Article Testing then scheduled to begin later in 2024. Timing and contract potential remain subject to testing and customer orders.
- A January 2023 cyber incident disrupted production and shipping at Newark and Virginia Beach for several weeks. Systems and production were restored; the company paid no ransom. A business-interruption insurance claim remained under review and was excluded from 2023 results; the $100 deductible was recorded.
- 2023 other income includes a $1,544 Employee Retention Credit claim. The filing says the claim was filed with the IRS; cash collection is not established in the supplied text.
- Key risks include customer concentration (one defense prime represented 15% of revenue), dependence on government and defense spending, supply constraints and inflation, variable-rate debt, China operations and trade exposure, foreign currency movements, lithium-battery safety, and execution of new products and growth. The company reported no goodwill or indefinite-lived intangible impairment in its 2023 annual test.
- The independent auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor was not engaged to express an opinion on internal-control effectiveness.
Most important facts for investors to verify
- Whether the $103.5 million year-end backlog converts to shipments and cash as expected, especially given the lower Communications Systems backlog and the exclusion of future IDIQ deliveries.
- Whether operating cash generation improves as receivables and inventory are converted to cash; 2023 operating cash flow was materially below net income.
- Revolver availability under borrowing-base limits, variable-rate interest exposure, and the ability to address the May 2025 revolver maturity.
- The status, timing and recoverability of the cyber-insurance claim, and the timing and collection of the ERC receivable.
- Progress and schedule for CWB testing and other development programs, along with the expected returns from higher R&D spending.
- Continued margin improvement, customer concentration and exposure to supply interruptions, defense budgets and foreign exchange.